1. The Board may establish a program to ensure the integrity of all testing performed by a cannabis independent testing laboratory by subjecting each such laboratory to random laboratory assurance checks.
2. If the Board establishes a program pursuant to subsection 1, each cannabis independent testing laboratory shall participate in the program.
3. If the Board establishes a program pursuant to subsection 1, as part of the program, the Board shall:
(a) Collect samples of cannabis or cannabis products from cannabis establishments that have already been tested by cannabis independent testing laboratories in amounts deemed sufficient by the Board;
(b) Remove identifying characteristics from and randomize such samples; and
(c) Provide each cannabis independent testing laboratory with a sample for analysis.
4. A cannabis independent laboratory that receives a sample from the Board shall perform such quality assurance tests upon the sample as the Board may require. Such tests may include, without limitation:
(a) Screening the sample for pesticides, heavy metals, chemical residues, herbicides, growth regulators and microbial analysis;
(b) A potency analysis to test for and quantify the presence of the following cannabinoids:
(1) THC;
(2) Tetrahydrocannabinolic acid;
(3) Cannabidiol;
(4) Cannabidiolic acid; and
(5) Cannabinol; and
(c) Such other quality assurance tests that the Board may require.
5. If the Board establishes a program pursuant to subsection 1, the Board shall adopt regulations necessary to carry out the program. Such regulations:
(a) Must require each cannabis independent testing laboratory to perform a random laboratory assurance check at least once every 6 months but not more frequently than once every 3 months.
(b) May modify the procedures and requirements set forth in this section if the Board determines that advances in science necessitate such a modification.
6. As used in this section, "random laboratory assurance check" means the evaluation of the performance of a cannabis independent testing laboratory in conducting quality assurance tests upon a sample if required by the Board under the program established pursuant to subsection 1.
(Added to NRS by 2019, 3810, effective July 1, 2020)